Xbrane Biopharma AB (publ) XBRANE.ST Stock
Xbrane Biopharma AB (publ) Price Chart
Xbrane Biopharma AB (publ) XBRANE.ST Financial and Trading Overview
| Xbrane Biopharma AB (publ) stock price | 0.37 SEK |
| Previous Close | 79.6 SEK |
| Open | 79.6 SEK |
| Bid | 79.2 SEK x 0 |
| Ask | 79.6 SEK x 0 |
| Day's Range | 79.2 - 80.1 SEK |
| 52 Week Range | 55.6 - 105 SEK |
| Volume | 13.67K SEK |
| Avg. Volume | 54.12K SEK |
| Market Cap | 2.32B SEK |
| Beta (5Y Monthly) | 1.359386 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.27 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 130 SEK |
XBRANE.ST Valuation Measures
| Enterprise Value | 2.09B SEK |
| Trailing P/E | N/A |
| Forward P/E | 5.5338454 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 20.664755 |
| Price/Book (mrq) | 5.936962 |
| Enterprise Value/Revenue | 18.682 |
| Enterprise Value/EBITDA | -13.06 |
Trading Information
Xbrane Biopharma AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.359386 |
| 52-Week Change | 20.06% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 105 SEK |
| 52 Week Low | 55.6 SEK |
| 50-Day Moving Average | 86.39 SEK |
| 200-Day Moving Average | 81.93 SEK |
XBRANE.ST Share Statistics
| Avg. Volume (3 month) | 54.12K SEK |
| Avg. Daily Volume (10-Days) | 76.2K SEK |
| Shares Outstanding | 29.22M |
| Float | 20.54M |
| Short Ratio | N/A |
| % Held by Insiders | 36.49% |
| % Held by Institutions | 21.09% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -173.73% |
| Operating Margin (ttm) | -154.12% |
| Gross Margin | 58.45% |
| EBITDA Margin | -143.055% |
Management Effectiveness
| Return on Assets (ttm) | -16.28% |
| Return on Equity (ttm) | -49.46% |
Income Statement
| Revenue (ttm) | 112.12M SEK |
| Revenue Per Share (ttm) | 4.28 SEK |
| Quarterly Revenue Growth (yoy) | 743.29% |
| Gross Profit (ttm) | 57.62M SEK |
| EBITDA | -160386000 SEK |
| Net Income Avi to Common (ttm) | -188860000 SEK |
| Diluted EPS (ttm) | -7.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 118.75M SEK |
| Total Cash Per Share (mrq) | 4.32 SEK |
| Total Debt (mrq) | 40.35M SEK |
| Total Debt/Equity (mrq) | 10.98 SEK |
| Current Ratio (mrq) | 1.826 |
| Book Value Per Share (mrq) | 13.357 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -296052992 SEK |
| Levered Free Cash Flow (ttm) | -242664496 SEK |
Profile of Xbrane Biopharma AB (publ)
| Country | Sweden |
| State | N/A |
| City | Solna |
| Address | Retzius vAeg 8 |
| ZIP | 171 65 |
| Phone | 46 8 55 90 56 00 |
| Website | https://www.xbrane.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 90 |
Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures, and sells biosimilars. The company is developing Ximluci, a ranibizumab biosimilar used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and visual impairment due to cordial neovascularization in adults. Its pre-clinical phase products include BIIB801, a biosimilar candidate for the treatment of rheumatoid arthritis, psoriasis, Crohn's disease, and axial spondylitis; Xdivane for skin cancer, lung cancer, renal cell cancer, head and neck cancer, and bladder and urinary tract cancer; Xtrudane for brain cancer, melanoma, lung cancer, kidney cell cancer, head and neck cancer, and bladder and urinary tract cancer; and Xdarzane for multiple melanoma. Xbrane Biopharma AB (publ) was incorporated in 2008 and is headquartered in Solna, Sweden.
Q&A For Xbrane Biopharma AB (publ) Stock
What is a current XBRANE.ST stock price?
Xbrane Biopharma AB (publ) XBRANE.ST stock price today per share is 0.37 SEK.
How to purchase Xbrane Biopharma AB (publ) stock?
You can buy XBRANE.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xbrane Biopharma AB (publ)?
The stock symbol or ticker of Xbrane Biopharma AB (publ) is XBRANE.ST.
Which industry does the Xbrane Biopharma AB (publ) company belong to?
The Xbrane Biopharma AB (publ) industry is Biotechnology.
How many shares does Xbrane Biopharma AB (publ) have in circulation?
The max supply of Xbrane Biopharma AB (publ) shares is 1.53B.
What is Xbrane Biopharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Xbrane Biopharma AB (publ) PE Ratio is now.
What was Xbrane Biopharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Xbrane Biopharma AB (publ) EPS is -1.27 SEK over the trailing 12 months.
Which sector does the Xbrane Biopharma AB (publ) company belong to?
The Xbrane Biopharma AB (publ) sector is Healthcare.
Xbrane Biopharma AB (publ) XBRANE.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm_PI OMXSPI | 947.32 SEK 92.47 USD |
-0.04
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Mid_Cap_GI OMXSMCGI | 796.9 SEK 77.79 USD |
-0.02
|
— — | — — | — — | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 456.92 SEK 44.6 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Mid_Cap_ISK_GI OMXNMCISKGI | 622.38 ISK 4.58 USD |
-0.43
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Mid_Cap_DKK_GI OMXNMCDKKGI | 439.38 DKK 64.42 USD |
-0.4
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2564.43 SEK 250.32 USD |
-0.59
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 6954.45 SEK 678.84 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Mid_Cap_PI OMXSMCPI | 1516.78 SEK 148.06 USD |
-0.02
|
— — | — — | — — | — - | — — |
| OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Mid_Cap_SEK_GI OMXNMCSEKGI | 548.69 SEK 53.56 USD |
+0.07
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Mid_Cap_EUR_GI OMXNMCEURGI | 439.19 EUR 480.1 USD |
-0.42
|
— — | — — | — — | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4086.93 SEK 398.94 USD |
-0.47
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}